‘BNB Microstrategy’ faces imminent Nasdaq delisting as price falls below threshold
Windtree, a biotech-turned BNB treasury firm, is facing delisting from the Nasdaq on August 21.
- Nasdaq is set to delist Windtree on August 21, following non-compliance with its $1 share price rule
- Windtree’s stock price lost 97.74% in the past six months, to $0.11
- Delisting would make it much harder for Windtree to gain access to public markets
Struggling biotech Windtree’s pivot to BNB treasuries could soon come to an end. On Tuesday, August 19, regulatory filings showed that Windtree, sometimes called “BNB Microstrategy,” is facing imminent delisting on Nasdaq over non-compliance.
According to the filing with the Securities and Exchange Commission, Nasdaq will delist Windtree on August 21. Namely, Nasdaq companies must trade above $1 per share, while Windtree, under the ticker WINT, is trading at $0.11.
Critically, the move could place Windtree’s pivot to BNB treasuries at risk. Specifically, the Nasdaq listing effectively turns Windtree into a leveraged play on BNB available on the public market. Without access to the Nasdaq, it would be more difficult for average investors to acquire Windtree’s stock.
Struggling Windtree pivoted to BNB treasuries
Windtree, a biotech firm, announced its pivot to a BNB treasury firm after years of slow business. In the past six months, its stock price has fallen 97.74% to its current level of $0.11.
On July 16, the company first announced plans to purchase $60 million worth of BNB tokens from Build and Build Corp., with the potential to acquire $140 million more. This put the company’s total financing up to $200 million for its BNB treasury.
Just a week later, on July 24, the firm announced securing another $520 million in financing. $500 would come from an equity line of credit agreement with an undisclosed financeer, and another $20 million from a direct stock purchase from Build and Build Corp.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
How much CPO demand will Nvidia Rubin Ultra generate? Bernstein: Optical value per Pod will increase fivefold
Bernstein believes that the co-packaged optics (CPO) and fiber demand driven by Nvidia's Rubin Ultra architecture will surge significantly, with the optical content per Pod rising from $1 million to $5.4 million. This will propel the size of Nvidia's optical ecosystem market to $46.8 billion by 2028 (a 91% annual increase). Although the industry faces supply bottlenecks with InP substrates, the outlook remains positive. The institution reiterates its “outperform” rating for Lumentum, Coherent, and Ciena.
UBS Q3 implements a two-way strategy with gold options, heavily invests in technology stocks, and builds positions in SK Hynix (SKHY.US)
UBS Group (UBS.US) has submitted its Q3 holdings report (13F) as of September 30, 2026.
SpaceX (SPCX.US) reportedly attempts “de-Nvidiaization” at the rack level: developing Kessel cabinets to bypass L6 compute boards, purchasing only chips
SemiAnalysis: SpaceX has developed its own Kessel cabinet, bypassing Nvidia's L6 cards to provide more options for manufacturing its own hardware.
$3.7 billion “data center power equipment prepayments” abandoned! What did "the most active buyer of gas turbines", SoftBank, see?
In the second quarter of fiscal year 2026, SoftBank reported a net loss of $7.1 billion, primarily due to a $3.7 billion impairment charge from a $9.5 billion advance payment for power generation equipment for US data centers—of which about $2.9 billion was non-refundable and effectively lost. The CFO admitted that SoftBank placed orders before the project plan was finalized, and is now conducting a comprehensive review of its procurement strategy. "The most aggressive purchaser of gas turbines has now written off the deposit in this way."
Crypto prices
More
